CalciMedica Inc.

About CalciMedica Inc.

CalciMedica is a biopharmaceutical company focused on developing CRAC (calcium release-activated calcium) channel inhibitors to treat life-threatening inflammatory diseases affecting the pancreas, kidney, and lung. Their mission is to address high unmet medical needs by creating therapies for acute and chronic inflammatory conditions with no approved disease-modifying treatments.

Products & Services

Auxora™:A proprietary intravenous formulation of a small molecule CRAC channel inhibitor in development for treating acute pancreatitis (AP) with SIRS and asparaginase-induced pancreatic toxicity (AIPT), conditions with no currently approved therapies.

Specialties

CRAC channel inhibition Inflammatory disease treatment Therapies for acute pancreatitis Therapies for kidney injury Therapies for lung conditions

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debt T: - FT: Debt	A: 32500000 MR: - FA: Up to $32.5 million FAN: 32500000	D: 2025-03-05 FD: 2025-03-05	1 investors
2	RT: Public Offering T: - FT: Public Offering	A: 10200000 MR: - FA: $10,200,000 FAN: 10200000	D: 2024-10-30 FD: 2024-10-30	1 investors
3	RT: Private Placement T: - FT: Private Placement	A: 55000000 MR: - FA: up to approximately $55 million FAN: 55000000	D: 2024-01-22 FD: 2024-01-22	6 investors

Debt Latest

2025-03-05

$32.5M

1 investor (Pro only)

Public Offering 2024-10-30

$10.2M

Private Placement 2024-01-22

$55.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Rachel Leheny

Chief Executive Officer

K

Kenneth A. Stauderman

Chief Scientific Officer

S

Sudarshan Hebbar

Chief Medical Officer

M

Michael J. Dunn

President & Chief Operating Officer

E

Eric W. Roberts

Chief Business Officer and Vice Chairman of the Board

J

John M. Dunn

General Counsel

View 21 more team members with Pro

Unlock Full Team Directory

Recent News

CalciMedica Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised